India seeks deeper global regulatory cooperation to strengthen pharma innovation, medicine access: Piyush Goyal
New Delhi, July 31
India is seeking closer cooperation among drug regulators across the world, supported by its expanding network of trade agreements, to improve access to affordable medicines while strengthening the country's position as a global hub for pharmaceutical innovation, Union Commerce and Industry Minister Piyush Goyal said.
In a post on X on Friday, Goyal said the two-day Global Drug Regulatory Conclave 2026, which commenced at Bharat Mandapam on Thursday, has brought together heads and senior officials of national drug regulatory authorities from across the world.
"India seeks closer cooperation among the world's medicine regulators, supported by our expanding network of trade agreements. This will enable faster access to high-quality, affordable medicines for patients worldwide while strengthening India's position as a global hub for pharmaceutical innovation," Goyal said.
Describing the event as India's flagship international forum on pharmaceutical regulatory cooperation and convergence, the minister said he was confident that the conclave would help deepen collaboration between India's pharmaceutical industry, global regulators and other stakeholders.
"Wishing the conclave great success in fostering deeper collaboration among the Indian pharmaceutical industry, global regulators, and stakeholders, paving the way for a more resilient, innovative, and patient-centric global healthcare ecosystem," he added.
According to the Ministry of Health, Union Health Minister Jagat Prakash Nadda, while addressing the inaugural session of the conclave, said trusted, science-based and transparent regulatory systems are essential for safeguarding public health, promoting innovation and ensuring timely access to safe, effective, high-quality and affordable medicines.
He also reaffirmed India's commitment to building a future-ready regulatory ecosystem through reforms, digital transformation and stronger quality standards.
Union Health Secretary Punya Salila Srivastava said regulatory systems must evolve through greater international cooperation, transparency, scientific excellence and mutual trust. She said India remains committed to strengthening its regulatory ecosystem through reforms, digital transformation, capacity building and internationally aligned standards, while calling for deeper global collaboration to ensure timely access to quality medicines and medical products.
— ANI
Reader Comments
This is exactly what we need. If regulators across countries work together, it will reduce duplication and speed up approvals. That means affordable medicines will reach patients faster. Very forward-looking move by the government.
Hope this doesn't just remain talk. We need concrete action on ground - faster approvals, better quality control, and actual collaboration. Otherwise these conclaves are just photo ops. Would love to see specific outcomes from this summit.
As someone working in pharma exports, I can tell you this is a game-changer. Regulatory harmonization means less paperwork, faster clearances, and more trust in Indian products globally. Great step towards making India a true global pharma hub!
Affordable medicines for everyone is the dream. During COVID, India showed the world what we're capable of. Now with stronger regulatory ties, we can make quality healthcare accessible to millions more. Kudos to the minister for pushing this agenda. 🙏
While I support the initiative, we must also ensure our domestic regulatory body CDSCO gets strengthened. International cooperation is good, but we can't compromise on our own quality standards. Balance is key. Let's make sure Indian patients benefit first.
N Nisha Z This is the kind of We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.